Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Nahid Tayebi, Loukia Parisiadou, Bahafta Berhe, et al.
Molecular Genetics and Metabolism (2017) Vol. 122, Iss. 4, pp. 198-208
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy E. McKinney, Pankaj Sharma, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 249
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 200
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson, Samantha F. Sedor, Ian McGeary, et al.
Neuron (2019) Vol. 105, Iss. 5, pp. 822-836.e7
Open Access | Times Cited: 110
Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
Raja Elizabeth Estes, Bernice Lin, Arnav Khera, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 57
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
Fabian Braun, Ahmed H. Abed, Dominik Sellung, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 29
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Ellen Hertz, Yu Chen, Ellen Sidransky
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 11
C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson’s disease
Ryan P. McGlinchey, Shannon M. Lacy, Kate Huffer, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 25, pp. 9973-9984
Open Access | Times Cited: 65
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 22
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson’s disease
Masashi Ikuno, Hodaka Yamakado, Hisako Akiyama, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 11, pp. 1894-1904
Open Access | Times Cited: 47
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Katharina Klatt‐Schreiner, Lucie Valek, Jun‐Suk Kang, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1822-1833
Open Access | Times Cited: 35
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease
Ioanna Alefanti, Christos Koros, Viktoria Tsami, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access
Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers
Emma N. Somerville, Lynne Krohn, Konstantin Senkevich, et al.
Molecular Neurobiology (2025)
Open Access
Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?
Tamar Farfel‐Becker, Jenny Do, Nahid Tayebi, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 9, pp. 631-643
Closed Access | Times Cited: 32
Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence
Alexandre Henriques, Laura Rouvière, Elodie Giorla, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9864-9864
Open Access | Times Cited: 16
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
Donghoon Kim, Heehong Hwang, Seulah Choi, et al.
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 31
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
Shani Blumenreich, Or B. Barav, Bethan J. Jenkins, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4966-4966
Open Access | Times Cited: 26
Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
Sophia R.L. Vieira, Anthony H.V. Schapira
Free Radical Biology and Medicine (2021) Vol. 175, pp. 42-55
Open Access | Times Cited: 19
Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model
Catherine Viel, Jennifer Clarke, Can Kayatekin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Cln3‐mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl‐protein thioesterases‐1 (Ppt1)‐protein and Ppt1‐enzyme activity in the lysosome
Abhilash P. Appu, Maria B. Bagh, Tamal Sadhukhan, et al.
Journal of Inherited Metabolic Disease (2019) Vol. 42, Iss. 5, pp. 944-954
Open Access | Times Cited: 19
Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
Jun Yup Lee, Oana C. Marian, Anthony S. Don
NeuroMolecular Medicine (2021) Vol. 23, Iss. 1, pp. 1-24
Closed Access | Times Cited: 14
Prodromal sensory neuropathy in Pink1−/−SNCAA53T double mutant Parkinson mice
Lucie Valek, Bao Tran, Annett Wilken‐Schmitz, et al.
Neuropathology and Applied Neurobiology (2021) Vol. 47, Iss. 7, pp. 1060-1079
Open Access | Times Cited: 14
Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
Adahir Labrador‐Garrido, Siying Zhong, Laura P. Hughes, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson’s disease and Dementia with Lewy bodies
Sreeganga S. Chandra, D. J. Vidyadhara, David Bäckström, et al.
Research Square (Research Square) (2024)
Closed Access | Times Cited: 1
Validation of anti-glucocerebrosidase antibodies for western blot analysis on protein lysates of murine and human cells
Wenduo Qi, Brad A. Davidson, Matthew Nguyen, et al.
Biochemical Journal (2018) Vol. 476, Iss. 2, pp. 261-274
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top